Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Rev. Méd. Clín. Condes ; 32(5): 570-576, sept.-oct. 2021. ilus, graf
Article in Spanish | LILACS | ID: biblio-1526064

ABSTRACT

La apnea obstructiva del sueño (AOS) y el síndrome hipoventilación-obesidad (SHO) son patologías que se encuentran estrechamente asociadas a la obesidad como principal factor de riesgo, hasta un 70% de los pacientes con AOS son obesos. Ambas patologías comparten procesos fisiopatológicos comunes, donde destaca la inflamación sistémica, lo que, sumado a la hipoxia crónica intermitente y la fragmentación del sueño característicos de la AOS, aumenta considerablemente el riesgo de presentar comorbilidades metabólicas como síndrome metabólico, alteraciones en el metabolismo de la glucosa (resistencia a la insulina y diabetes mellitus tipo 2), y hígado graso metabólico. En esta revisión narrativa, se describirán los mecanismos identificados en estas asociaciones, así como la prevalencia y la evidencia sobre el tratamiento de la AOS y del SHO


Obstructive sleep apnea (OSA) and obesity-hypoventilation syndrome (OHS) are pathologies that are closely associated with obesity as the main risk factor, up to 70% of patients with OSA are obese. Both pathologies share common pathophysiological processes, where systemic inflammation stands out, which, added to the intermittent chronic hypoxia and sleep fragmentation characteristic of OSA, considerably increases the risk of presenting metabolic comorbidities such as metabolic syndrome, alterations in the metabolism of the glucose (insulin resistance and type 2 diabetes mellitus), and metabolic fatty liver. In this narrative review, the mechanisms identified in these associations will be described, as well as the prevalence and evidence on the treatment of OSA and OHS


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Sleep Apnea, Obstructive/metabolism , Sleep Apnea, Obstructive/epidemiology , Obesity Hypoventilation Syndrome/metabolism , Obesity Hypoventilation Syndrome/epidemiology , Risk Factors , Sleep Apnea, Obstructive/therapy , Metabolic Syndrome , Hypoxia/physiopathology
2.
Arch. cardiol. Méx ; 91(1): 7-16, ene.-mar. 2021. tab
Article in Spanish | LILACS | ID: biblio-1152855

ABSTRACT

Resumen Introducción: Las alteraciones del intercambio gaseoso se han reconocido en la obesidad mórbida; sin embargo, no se conoce su comportamiento conforme se incrementa el índice de masa corporal. Objetivo: Conocer el comportamiento del intercambio gaseoso a la altura de la Ciudad de México en el desarrollo de obesidad mórbida. Métodos: Mediante un diseño transversal analítico se estudió a sujetos pareados por género y edad de cuatro grupos diferentes de índice de masa corporal (kg/m2): normal (18.5-24.9), sobrepeso (25-29.9), obesidad (30-39.9) y obesidad mórbida (≥ 40). Se obtuvieron sus antecedentes patológicos y demográficos, variables de gasometría arterial y espirometría simple. Las variables se determinaron de acuerdo con las características de la muestra; las diferencias entre grupos se realizaron mediante Anova de una vía con ajuste de Bonferroni, así como la correlación de Pearson para las variables relacionadas. Una p < 0.05 se consideró con significación estadística. Resultados: Se estudió a 560 pacientes en cuatro grupos. La edad promedio fue de 49 ± 11 años. La mayor frecuencia de diabetes mellitus (34.29%), hipertensión arterial (50%) e hiperlipidemia (36.43%) se registró en el grupo de obesidad, y la de roncador (73.57%) en la obesidad mórbida. Se identificaron diferencias desde el grupo normal respecto de la obesidad mórbida: PaCO2 31.37 ± 2.08 vs. 38.14 ± 5.10 mmHg; PaO2 68.28 ± 6.06 vs. 59.86 ± 9.28 mmHg y SaO2 93.51 ± 1.93 vs. 89.71 ± 5.37%, todas con p = 0.0001. Correlación IMC-PaCO2: 0.497, e IMC-PaO2: -0.365, p = 0.0001, respectivamente. Conclusiones: A la altitud de la Ciudad de México y con índice de masa corporal > 30 kg/m2, las variables relacionadas con el intercambio gaseoso y espirometría simple comienzan a deteriorarse; son evidentes con IMC > 40 kg/m2.


Abstract Introduction: Alterations of gas exchange have been recognized in morbid obesity, however, it is not known how their behavior would be as the body mass index increases. Objective: To know the behavior of gas exchange at the level of Mexico City in the development of morbid obesity. Methods: Through analytical design, subjects matched by gender and age were studied from four different groups of body mass index (kg/m2), normal (18.5-24.9), overweight (25-29.9), obesity (30-39.9) and morbid obesity (≥ 40). Their pathological and demographic antecedents, arterial blood gas and simple spirometry variables were obtained. The variables were shown according to their sample characteristic. The differences between groups were made using one way Anova with Bonferroni adjustment, as well as Pearson’s correlation for the related variables. Statistical significance was considered with p < 0.05. Results: 560 subjects were studied in 4 groups. The average age 49 ± 11 years old. The highest frequency of diabetes mellitus (34.29%), arterial hypertension (50%) and hiperlipidemia (36.43%) was in the obesity group, and being snoring (73.57%) in morbid obesity. There were differences from the normal group versus. morbid obesity: PaCO2 31.37 ± 2.08 versus. 38.14 ± 5.10 mmHg; PaO2 68.28 ± 6.06 versus. 59.86 ± 9.28 mmHg and SaO2 93.51 ± 1.93 versus. 89.71 ± 5.37%, all with p = 0.0001. The IMC-PaCO2 correlation: 0.497, and IMC-PaO2: −0.365, p = 0.0001 respectively. Conclusions: At the altitude of Mexico City and body mass index > 30 kg/m2 the variables related to gas exchange and simple spirometry begin to deteriorate; are evident with BMI > 40 kg/m2.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Body Mass Index , Pulmonary Gas Exchange , Altitude , Obesity/physiopathology , Urban Health , Cross-Sectional Studies , Mexico
3.
J. bras. pneumol ; 44(6): 510-518, Nov.-Dec. 2018. tab, graf
Article in English | LILACS | ID: biblio-984604

ABSTRACT

ABSTRACT Obesity hypoventilation syndrome (OHS) is defined as the presence of obesity (body mass index ≥ 30 kg/m²) and daytime arterial hypercapnia (PaCO2 ≥ 45 mmHg) in the absence of other causes of hypoventilation. OHS is often overlooked and confused with other conditions associated with hypoventilation, particularly COPD. The recognition of OHS is important because of its high prevalence and the fact that, if left untreated, it is associated with high morbidity and mortality. In the present review, we address recent advances in the pathophysiology and management of OHS, the usefulness of determination of venous bicarbonate in screening for OHS, and diagnostic criteria for OHS that eliminate the need for polysomnography. In addition, we review advances in the treatment of OHS, including behavioral measures, and recent studies comparing the efficacy of continuous positive airway pressure with that of noninvasive ventilation.


RESUMO A síndrome de obesidade-hipoventilação (SOH) é definida pela presença de obesidade (índice de massa corpórea ≥ 30 kg/m2) e hipercapnia arterial diurna (PaCO2 ≥ 45 mmHg), na ausência de outras causas. A SOH é frequentemente negligenciada e confundida com outras patologias associadas à hipoventilação, em particular à DPOC. A importância do reconhecimento da SOH se dá por sua elevada prevalência, assim como alta morbidade e mortalidade se não tratada. Na presente revisão, abordamos os recentes avanços na fisiopatologia e no manejo da SOH. Revisamos a utilidade da medição do bicarbonato venoso como rastreamento e os critérios diagnósticos que descartam a necessidade de polissonografia. Destacamos ainda os avanços no tratamento da SOH, incluindo medidas comportamentais, e estudos recentes que comparam a eficácia do uso de pressão positiva contínua nas vias aéreas e de ventilação não invasiva.


Subject(s)
Humans , Obesity Hypoventilation Syndrome/diagnosis , Obesity Hypoventilation Syndrome/physiopathology , Obesity Hypoventilation Syndrome/therapy , Obesity Hypoventilation Syndrome/epidemiology
4.
Rev. chil. enferm. respir ; 34(1): 10-18, 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-959404

ABSTRACT

Resumen Introducción: La ventilación mecánica no invasiva domiciliaria (VMNID) se entrega en Chile desde el año 2008 mediante un programa público. Incluye equipamiento y profesionales. Objetivos: 1) Caracterizar el perfil socio-demográfico y clínico del usuario adulto con VMNID y 2) Proponer mejoras de atención socio-sanitaria. Método. Estudio descriptivo transversal, mediante entrevista presencial domiciliaria y revisión de bases de datos oficiales. Muestra de 267 sujetos, ambos géneros, mayores de 20 años, con Falla Respiratoria Global Crónica (FRGC) en VMNID. En 2016 había 413 pacientes activos. Resultados: Mujeres 144 (53,9%), edad media 58,6 ± 18 años. 25,5% tienen EPOC y 24% síndrome hipoventilación obesidad, la PaCO2 promedio de ingreso al programa fue de 59 ± 11 mmHg. Ventilados desde 3,2 ± 2,4 años, por 7,6 ± 2,4 h/día. Sujetos "sin instrucción" y con "educación básica incompleta" representan el 40,7% de la muestra. 46,4% eran jubilados, 3% vive en mediaguas, 19,8% reside como allegado, 49% no contaba con pareja, el 4,8% vivía solo, 68,6% eran dependientes de oxígeno. Test de Golberg estuvo alterado en un 40%. 17,7% "posee mayor limitación, incapaz de realizar el autocuidado". Conclusiones: Nuestros pacientes tienen un deterioro socio-demográfico y clínico severo, por baja escolaridad, predominio de adultos mayores, mayor incapacidad laboral, son enfermos más graves con niveles basales de PaCO2 más altos, en comparación a estudios europeos. Los programas de VMNID deben adoptar un enfoque socio-sanitario y estar insertos en la red de salud tanto en servicio social, salud cardiovascular y mental.


Introduction: Non-invasive home mechanical ventilation (NIHMV) is delivered in Chile since 2008 throughout a public program, including equipment and professionals. Objectives: 1) Characterize the socio-demographic and clinical profile of the adult patient under NIHMV and 2) Propose improvements in social health care. Methodology: Descriptive cross-sectional study, through face-to-face home interview and review of official databases. Sample of 267 subjects, both gender, over 20 years-old, with Chronic Global Respiratory Failure (CGRF) in NIHMV. In 2016 there were 413 active patients. Results: Women 144 (53.9%), mean age 58.6 ± 18 years-old; 25.5% had COPD and 24% had a hypoventilation obesity syndrome, average PaCO2 at the time of admission to program was 59 ± 11 mmHg, they were ventilated since 3.2 ± 2.4 years, 7.6 ± 2.4 h a day. Subjects "without instruction" and with "incomplete basic education" represents 40.7% of the sample. 46.4% were retired persons; 3% lived in a precarious hut; 19.8% cohabited with relatives or close friends; 49% did not have a partner; 4.8% lived alone; 68.6% was oxygen dependent; 40% had an altered Golberg test; 17.7% "has a major limitation, unable to perform self-care". Conclusions: Our patients have a severe socio-demographic and clinical deterioration, due to low schooling level, predominance of older adults, a major incapacity for working and patients have a more severe disease with higher baseline PaCO2 levels, compared to European studies. NIHMV programs must adopt a social health approach and be inserted into the health network in social service, and cardiovascular and mental health programs.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Respiration, Artificial , Noninvasive Ventilation/methods , Home Care Services , Obesity Hypoventilation Syndrome , Chile , Demography , Epidemiology, Descriptive , Age Factors , Pulmonary Disease, Chronic Obstructive/physiopathology , Health Services Programming
5.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 1970-1974, 2016.
Article in Chinese | WPRIM | ID: wpr-493870

ABSTRACT

Objective To compare the effect of continuous positive airway pressure (CPAP)and bilevel positive airway pressure(BiPAP)on the cardiac structure and function of patients with obstructive sleep apnea and hypopnea syndrome(OSAHS).Methods 100 patients with OSAHS were selected as the research subjects.The patients were randomly divided into two groups by digital table method,CPAP group had 50 cases,adopted the CPAP ventilation mode,BiPAP group had 50 cases,adopted the BiPAP ventilation mode.The heart rate,blood pressure, blood brain natriuretic peptide(BNP),nitric oxide(NO),endothelin -1 protease,matrix metalloprotein 9(MMP -9), C -reactive protein (CRP) and polysomnography (PSG) related indicators,cardiac structure and function and endothelial function changes before and after treatment were observed in the two groups,compared the clinical effect of the two modes.Results Before treatment,in both groups,there were no statistical differences in blood pressure,heart rate,BNP,NO,endothelin -1,MMP -9,CRP,PSG related indicators,cardiac structure and function,endothelial function.After six months of noninvasive ventilator treatment,results of the heart rate,systolic pressure,diastolic blood pressure,blood oxygen saturation,oxygen partial pressure,the BNP,endothelin -1,NO,MMP -9,CRP,body mass index,the Epworth sleepiness scale(ESS),Apnea hypoventilation index(AHI),oxygen and lowest at night,aortic di-ameter(AO),left ventricular inner diameter (LA),right ventricular(RV)inside diameter,left ventricular ejection fraction(LVEF),pulmonary artery systolic pressure(PASP)of the CPAP group were (79.83 ±11.47)times/min, (114.06 ±11.45)mmHg,(72.44 ±7.38)mmHg,(97.6 ±1.45)%,(93.17 ±1.86)mmHg,(110.78 ±38.32)ng/L, (17.58 ±2.07)ng/L,(8.55 ±0.55)μmol/L,(372.73 ±189.00)μg/L,(3.34 ±2.29)mg/L,(23.87 ±1.59), (0.98 ±0.70),(0.65 ±0.30),(94.04 ±1.62)%,(31.52 ±2.17 )mm,(31.19 ±1.09 )mm,(20.86 ± 1.69)mm,(61.13 ±5.02)%,(20.74 ±5.49)mmHg.which of the BiPAP group were (80.96 ±8.56)times/min, (114.58 ±9.34)mmHg,(71.67 ±8.57)mmHg,(96.96 ±1.43)%,(94.52 ±1.66)mmHg,(87.63 ±28.33)ng/L, (17.76 ±2.20)ng/L,(8.54 ±0.52)μmol/L,(359.63 ±268.95)μg/L,(4.96 ±2.00)mg/L,(24.15 ±1.65), (0.85 ±0.75 ),(0.58 ±0.19 ),(94.50 ±1.18)%,(31.73 ±1.57 )mm,(31.97 ±1.12)mm,(21.58 ± 2.43)mm,(62.24 ±5.79)%,(21.45 ±3.76)mmHg.In the oxygen partial pressure,the BNP,MMP -9,CRP,ESS score,AHI,LA,LVEF and other indicators,BiPAP mode were better than CPAP mode(t =2.13,4.32,2.13,4.32, 1.39,4.93,2.58,4.36,all P <0.05 ).Conclusion BiPAP mode and CPAP mode can improve cardiovascular function in patients with OSAHS,improve the symptoms of low ventilation,reduce obesity,but in terms of reducing cardiac load,improve blood vessel function,BiPAP mode is better than CPAP.

6.
Sleep Medicine and Psychophysiology ; : 30-34, 2015.
Article in Korean | WPRIM | ID: wpr-153419

ABSTRACT

Obesity hypoventilation syndrome (OHS) is characterized by severe obesity, excessive daytime sleepiness, hypoxemia and hypercapnea. Because OHS mimics pulmonary hypertension or cor pulmonale, clinicians should recognize and treat this syndrome appropriately. A 58-year-old female visited the emergency room because of dyspnea. She was obese and had kyphoscoliosis. The patient also experienced snoring, recurrent choking during sleep and daytime hypersomnolence which worsened after gaining weight in the recent year. The arterial blood gas analysis showed she experienced hypoxemia and hypercapnea not only during nighttime but also daytime. We suspected OHS and the patient underwent polysomnography to confirm whether obstructive sleep apnea was present. During the polysomnography test, sleep obstructive apnea was observed and apnea-hypopnea index was 9.2/hr. The patient was treated with bilevel positive airway pressure therapy (BiPAP). After BiPAP for 4 days, hypoxemia and hypercapnia were resolved and she is currently well without BiPAP. We report a case successfully treated with clinical improvement by presuming OHS early in a patient who had typical OHS symptoms, even while having other conditions which could cause hypoventilation.


Subject(s)
Female , Humans , Middle Aged , Airway Obstruction , Hypoxia , Apnea , Blood Gas Analysis , Disorders of Excessive Somnolence , Dyspnea , Emergency Service, Hospital , Hypercapnia , Hypertension, Pulmonary , Hypoventilation , Obesity Hypoventilation Syndrome , Obesity, Morbid , Polysomnography , Pulmonary Heart Disease , Sleep Apnea, Obstructive , Snoring
7.
Chinese Journal of Primary Medicine and Pharmacy ; (12): 2327-2330, 2015.
Article in Chinese | WPRIM | ID: wpr-467177

ABSTRACT

Objective To investigate the application value of nasopharyngeal airway combined with polysom-nography in positing relieve airway obstruction before surgery for patients with obstructive sleep apnea-hypopnea syn-drom(OSAHS).Methods 69 patients with OSAHS were underwent consecutive 3 nights of sleep monitoring.At first night,the polysomnography figures were detected by using 36 polysomnography.At second night,patients were wearing nasopharyngeal airway all night and undergoing polysomnography figure monitoring.At third night,the airway pressures were measured by using ApneaGraph sleep monitoring and obstructive positioning system.The indicators of AHI, LSaO2 ,SaO2 and SaO2 <90% T before and after wearing nasopharyngeal airway were compared.The patients were divided into the treatment success group(S group)and treatment failure group(F group),according to AHI change before and after wearing nasopharyngeal airway.The indicators of the two groups were compared.The AHI in the lower part and proportion of lower portions blocking in the total congestion events under the ApneaGraph monitoring system were analyzed.Results 69 patients were successfully implanted nasopharyngeal airway,without nasal trauma,nasal bleeding,etc.63 cases of patients(91.3%)were well tolerated.The AHI and SaO2 <90% T at second night were lower than the first night,while LSaO2 and SaO2 were higher than the first night,the differences were statistically significant(t =13.811,13.307,10.852,4.277,all P <0.05).45 cases(71.4%)were in S group and 18 cases (28.6%)were in F group.LSaO2 in S group was higher than F group,while the lower AHI and lower portions blocking ratio were lower than F group,the differences were statistically significant(t =2.534,14.925,9.541,all P <0.05).Pearson correlation analysis showed the AHI at second night were positive correlated with the lower AHI and lower portions blocking ratio at third night(r =0.638,0.510,all P <0.05).Conclusion Nasopharyngeal airway combined with polysomnography could locate the overnight airway obstruction sites of OSAHS patients,and could be used as a simple base for locating before surgery for relieving upper airway obstruction.

8.
Chinese Journal of Applied Clinical Pediatrics ; (24): 251-254, 2014.
Article in Chinese | WPRIM | ID: wpr-733296

ABSTRACT

Patients with hypoventilation syndrome present with hypercapnia and hypoxemia due to alveolar hypoventilation.It is an uncommon but important group of respiratory control disorder which can increase the mortality rate in children,and it is under diagnosed by some pediatricians.In children,hypoventilation could be found in patient with congenital central respiratory control abnormality,morbid obesity,restrict chest wall abnormalities,and neural muscular diseases.Children manifested with head,fatigue,sleepiness,and cognitive defects.If left untreated,patient may develop pulmonary hypertension and cor pulmonale,even sudden death.The symptoms usually initiate at night and therefore sometimes neglect by physicians.Non-invasive ventilation is the major therapeutic method which has been used successfully in children.

9.
J. bras. pneumol ; 36(supl.2): 47-52, jun. 2010. ilus, tab
Article in Portuguese | LILACS | ID: lil-560654

ABSTRACT

Tanto SHO como as doenças neuromusculares estão relacionadas à hipoventilação durante o sono. Define-se SHO como a combinação de obesidade, hipercapnia e hipoxemia crônica durante a vigília que se agrava durante o sono. Em 90 por cento dos casos, SHO está associada à apneia obstrutiva do sono. O diagnóstico baseia-se na presença de hipoventilação diurna e hipertensão pulmonar que não são justificadas por alterações da função pulmonar. A mortalidade dos pacientes com SHO é maior que aquela de pacientes sem hipoventilação e controlados para obesidade. As doenças neuromusculares são representadas principalmente pelas distrofias musculares. A progressão para insuficiência respiratória crônica surge como consequência da fraqueza dos músculos respiratórios e da limpeza inadequada das vias aéreas, causando atelectasias e pneumonias. Quando há uma redução maior que 50 por cento da forca muscular respiratória, ocorre uma diminuição na CV. A medida do pico de fluxo da tosse < 160 L/min está associada à limpeza inadequada das vias aéreas, e, com valores em torno de 270 L/min, há indicação de uso de técnicas de tosse assistida. A apneia obstrutiva do sono geralmente agrava a hipoventilação durante o sono. O suporte pressórico não invasivo durante a noite pode aumentar a sobrevida, melhorar os sintomas e a hipoventilação diurna. Além disso, no caso de doenças neuromusculares, pode diminuir o declínio da função pulmonar. A oxigenoterapia pode ser necessária nos casos de SHO.


Sleep hypoventilation is seen in patients with neuromuscular disease, as well as in those with obesity hypoventilation syndrome (OHS), which is defined as the combination of obesity, chronic hypercapnia, and hypoxemia during wakefulness that is aggravated during sleep. In 90 percent of cases, OHS is accompanied by obstructive sleep apnea. The diagnosis of OHS is based on hypoventilation and pulmonary hypertension that cannot be explained by alterations in pulmonary function. The mortality of patients with OHS is greater than is that of obese patients without hypoventilation. The principal neuromuscular diseases associated with OHS are the muscular dystrophies. The progression to chronic respiratory failure results from respiratory muscle weakness and impaired airway secretion clearance, causing atelectasis and pneumonia. With a decrease of greater than 50 percent in respiratory muscle strength, there is a reduction in VC. Cough peak flow < 160 L/min is associated with impaired airway secretion clearance, and values near 270 L/min indicate the need for assisted cough techniques. Obstructive sleep apnea usually worsens sleep hypoventilation. Noninvasive ventilation during sleep can improve survival, symptoms, and hypoventilation during wakefulness, as well as being able to improve pulmonary function in patients with neuromuscular disease. Patients with OHS can require oxygen therapy.


Subject(s)
Humans , Neuromuscular Diseases/complications , Obesity Hypoventilation Syndrome/etiology , Continuous Positive Airway Pressure , Obesity Hypoventilation Syndrome/diagnosis , Obesity Hypoventilation Syndrome/therapy
10.
Journal of the Korean Neurological Association ; : 836-839, 2005.
Article in Korean | WPRIM | ID: wpr-16335

ABSTRACT

Obesity-Hypoventilation syndrome (OHS) is characterized by morbid obesity, hypoxia, and hypercapnea during wakefulness without parechymal lung disease or severe obstructive sleep apnea. A woman was admitted because of mental deterioration and diagnosed as OHS on the basis of obesity and hypoventilation, while awake, after ruling out other causes. By bilevel positive airway pressure (BiPAP) therapy, hypercapnea and hypoxia were resolved. We report that BiPAP can be an effective treatment for severe hypercapnea and hypoxia in OHS, which obviate the need for invasive endotracheal intubation.


Subject(s)
Female , Humans , Hypoxia , Hypoventilation , Intubation, Intratracheal , Lung Diseases , Obesity , Obesity Hypoventilation Syndrome , Obesity, Morbid , Sleep Apnea, Obstructive , Wakefulness
SELECTION OF CITATIONS
SEARCH DETAIL